Impaired cytoplasmic-nuclear transport of hypoxia-inducible factor-1α in amyotrophic lateral sclerosis

Brain Pathology

Volumn 23, Issue 5, 2013, Pages 534-546

  Nagara, Yuko ^a   Tateishi, Takahisa ^a   Yamasaki, Ryo ^a   Hayashi, Shintaro ^a   Kawamura, Mami ^a   Kikuchi, Hitoshi ^a   Iinuma, Kyoko Motomura ^a   Tanaka, Masahito ^a   Iwaki, Toru ^a   Matsushita, Takuya ^a   Ohyagi, Yasumasa ^a   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; hypoxia inducible factor 1 ; impaired cytoplasmic nuclear transport; mutant superoxide dismutase 1; vascular endothelial growth factor

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KARYOPHERIN BETA; NUCLEOPORIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HORN CELL; ARTICLE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN EXPRESSION; SPINAL CORD;

AMYOTROPHIC LATERAL SCLEROSIS; HYPOXIA-INDUCIBLE FACTOR-1Α; IMPAIRED CYTOPLASMIC-NUCLEAR TRANSPORT; MUTANT SUPEROXIDE DISMUTASE 1; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ACTIVE TRANSPORT, CELL NUCLEUS; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BETA KARYOPHERINS; FEMALE; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PORE COMPLEX PROTEINS; PHOSPHOPYRUVATE HYDRATASE; SPINAL CORD; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84882287457     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12040     Document Type: Article

References (49)

1. Andrus PK, Fleck TJ, Gurney ME, Hall ED, (1998) Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 71: 2041-2048.
2. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Comm 351: 602-611.
3. Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, et al (2006) IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 177: 5574-5584.
4. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, et al (2004) VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429: 413-417.
5. Barber SC, Mead RJ, Shaw PJ, (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762: 1051-1067.
6. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH Jr, (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42: 644-654.
7. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR, (2000) Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48: 285-296.
8. Brockington A, Wharton SB, Fernando M, Gelsthorpe CH, Baxter L, Ince PG, et al (2006) Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 65: 26-36.
9. Depping R, Steinhoff A, Schindler SG, Friedrich B, Fagerlund R, Metzen E, et al (2008) Nuclear translocation of hypoxia-inducible factors (HIFs): involvement of the classical importin α/β pathway. Biochim Biophys Acta Mol Cell Res 1783: 394-404.
10. Fujita Y, Yamauchi Y, Shibayami K, Ando M, Honda M, Nagata Y, (1996) Decreased cytochrome oxidase c but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cord of patients with amyotrophic lateral sclerosis. J Neurosci Res 45: 276-281.
11. Fukuda R, Hirota K, Fan F, Young DJ, Lee ME, Gregg LS, (2002) Insulin like growth factor 1 induces HIF-1α-mediated VEGF expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signalling in colon cancer cells. J Biol Chem 277: 38205-38211.
12. Fushimi K, Long C, Jayaram N, Chen X, Li L, Wu JY, (2011) Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein Cell 2: 141-149.
13. Ito D, Seki M, Tsunoda Y, Uchiyama H, Suzuki N, (2010) Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann Neurol 69: 152-162.
14. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA, (2002) Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A 99: 11946-11950.
15. Kalverda B, Pickersgill H, Shloma V, Fornerod M, (2010) Nucleoporins directly stimulate expression of developmental and cell-cycle genes inside the nucleoplasm. Cell 140: 360-371.
16. Kikuchi H, Furuta A, Nishioka K, Suzuki SO, Nakabeppu Y, Iwaki T, (2002) Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis. Acta Neuropathol 103: 408-414.
17. Kikuchi H, Yamada T, Furuya H, Doh-ura K, Ohyagi Y, Iwaki T, Kira J, (2003) Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis. Acta Neuropathol 105: 462-468.
18. Kinoshita Y, Ito H, Hirano A, Kengo F, Wate R, Nakamura M, et al (2009) Nuclear contour irregularity and abnormal transporter protein distribution in anterior horn cells in ALS. J Neuropathol Exp Neurol 68: 1184-1192.
19. Kwiatkowski JTJ, Bosco DA, LeClerc LA, Tamrazian E, Vanderburg CR, Russ C, et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205-1208.
20. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, et al (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34: 383-394.
21. Mali Y, Zisapels N, (2008) Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase. Neurobiol Dis 32: 133-141.
22. Mali Y, Zisapels N, (2010) A novel decoy that interrupts G93A-superoxide dismutase gain of interaction with malate dehydrogenase improves survival in an amyotrophic lateral sclerosis cell model. J Med Chem 52: 5442-5448.
23. Melchior F, Guan T, Yokoyama N, Nishimoto T, Gerace L, (1995) GTP hydrolysis by Ran occurs at the nuclear pore complex in an early step of protein import. J Cell Biol 131: 571-581.
24. Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, Connor JR, (2009) A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 72: 14-19.
25. Nakahara J, Kanekura K, Nawa M, Aiso S, Suzuki N, (2009) Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis. J Clin Invest 119: 169-181.
26. Neusch C, Bähr M, Schneider-Gold C, (2007) Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease? Muscle Nerve 35: 712-724.
27. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, et al (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28: 131-138.
28. Pemberton LF, Paschal PM, (2005) Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 6: 187-198.
29. Pesiridis GS, Virginia M, Lee Y, Trojanowski JQ, (2009) Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet 18: 156-162.
30. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K, (1998) Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273: 8413-8418.
31. Rosenstein JM, Mani N, Khaibullina A, Krum JM, (2003) Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons. J Neurosci 23: 11036-11044.
32. Sargsyan SA, Monk PN, Shaw PJ, (2005) Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51: 241-253.
33. Shefield LG, Miskiewicz HB, Tannenbaum LB, Mirra SS, (2006) Nuclear pore complex proteins in Alzheimer disease. J Neuropathol Exp Neurol 65: 45-54.
34. Silverman WF, Krum JM, Mani N, Rosenstein JM, (1999) Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 90: 1529-1541.
35. Sondell M, Lundborg G, Kanje M, (1999) Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res 846: 219-228.
36. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, et al (2005) Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8: 85-92.
37. Storr HL, Clark AJL, Priestley JV, Michael JG, (2005) Identification of the sites of expression of triple a syndrome mRNA in the rat using in situ hybridisation. Neuroscience 131: 113-123.
38. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA, (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111: 1843-1851.
39. Takahashi H, Egawa S, Piao YS, Hayashi S, Yamada M, Shimohata T, et al (2001) Neuronal nuclear alterations in dentatorubral-pallidoluysian atrophy: ultrastructural and morphometric studies of the cerebellar granule cells. Brain Res 2001: 12-19.
40. Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motomura K, et al (2006) Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 65: 816-825.
41. Tateishi T, Yamasaki R, Tanaka M, Matsushita T, Kikuchi H, Isobe N, et al (2010) CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J Neuroimmunol 222: 76-81.
42. Tolosa L, Mir M, Asensio VJ, Olmos G, Llado J, (2008) Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J Neurochem 105: 1080-1090.
43. Tolosa L, Mir M, Olmos G, Llado J, (2009) Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition. Neuroscience 158: 1348-1355.
44. Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W, (2006) The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 1762: 1068-1082.
45. Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323: 1208-1211.
46. Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, Jin K, (2007) Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci 27: 304-307.
47. Westra J, Brouwer E, Bos R, Doornbos-van der Meer B, Kallenberg CG, Limburg PC, (2007) Regulation of cytokine-induced HIF-1alpha expression in rheumatoid synovial fibroblasts. Ann New York Acad Sci 1108: 340-348.
48. Xu Y, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H, et al (2010) Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 30: 10851-10859.
49. Zhang J, Ito H, Wate R, Ohnishi S, Nakano S, Kusaka H, (2006) Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Acta Neuropathol 112: 673-680.